Literature DB >> 15596953

Recent progress in the epidemiology of atrial fibrillation.

Robert T Greenlee1, Humberto Vidaillet.   

Abstract

PURPOSE OF REVIEW: Atrial fibrillation is a common arrhythmia with serious health consequences. This review explores contributions to the characterization and control of atrial fibrillation made by recent epidemiologic efforts. RECENT
FINDINGS: Topics included in this review include the classification and clinical progression of atrial fibrillation, the burden atrial fibrillation places on the individual and on the health care delivery system, temporal trends in the occurrence and effect of atrial fibrillation, and novel predictors and risk factors. In light of the clinically relevant classification system used in the 2001 American College of Cardiology/American Heart Association/European Society of Cardiology Practice Guidelines for atrial fibrillation, recent estimates of pattern-specific recurrence and progression rates are described, along with insights into the incidence and prognosis of primary and secondary atrial fibrillation. Important new studies from North America and Europe quantifying the alarming health care burden and economic effect of atrial fibrillation are summarized. A discussion of several novel risk factors recently found to be associated with the development of atrial fibrillation is also included.
SUMMARY: Better characterization of the predictors, natural history, and clinical course of atrial fibrillation should ultimately support improvements in prevention, clinical decision making, and patient communication. A fuller comprehension of the current and future impact of atrial fibrillation can assist in planning health care delivery from the local facility to the international arena. Finally, there is a growing recognition that unraveling the complex interplay between atrial fibrillation and other associated diseases and their common risk factors may hold promise of deep insights into the fundamental nature of cardiovascular diseases.

Entities:  

Mesh:

Year:  2005        PMID: 15596953

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  9 in total

1.  A cohort study examination of established and emerging risk factors for atrial fibrillation: the Busselton Health Study.

Authors:  Matthew Knuiman; Tom Briffa; Mark Divitini; Derek Chew; John Eikelboom; Brendan McQuillan; Joseph Hung
Journal:  Eur J Epidemiol       Date:  2014-01-04       Impact factor: 8.082

2.  The cost effectiveness of anticoagulation management services for patients with atrial fibrillation and at high risk of stroke in the US.

Authors:  Patrick W Sullivan; Thomas W Arant; Samuel L Ellis; Heather Ulrich
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

3.  Prevalence, clinical correlates and treatment of permanent atrial fibrillation among the elderly: insights from the first prospective population-based study in rural Greece.

Authors:  Ilias Ninios; Harilaos Bogossian; Markus Zarse; Fotini Lazaridou; Kyriakos Dimitriadis; Vlasios Ninios; Bernd Lemke; George Louridas
Journal:  J Thromb Thrombolysis       Date:  2010-07       Impact factor: 2.300

4.  Atrial flutter versus atrial fibrillation in a general population: differences in comorbidities associated with their respective onset.

Authors:  Ravi K Mareedu; Ihab B Abdalrahman; Kodlipet C Dharmashankar; Juan F Granada; Po-Huang Chyou; Param P Sharma; Peter N Smith; John J Hayes; Robert T Greenlee; Humberto Vidaillet
Journal:  Clin Med Res       Date:  2009-11-17

5.  Prevalence and mortality of patients with myocardial infarction and reduced left ventricular ejection fraction in a defined community: relation to the second multicenter automatic defibrillator implantation trial.

Authors:  Param P Sharma; Robert T Greenlee; Kelley P Anderson; Po-Huang Chyou; Hector J Osorio; Peter N Smith; John H Hayes; Humberto Vidaillet
Journal:  J Interv Card Electrophysiol       Date:  2007-09-06       Impact factor: 1.900

Review 6.  New antiarrhythmic drugs for the treatment of atrial fibrillation.

Authors:  Jörn Schmitt; Joachim R Ehrlich; Stefan H Hohnloser
Journal:  Herz       Date:  2008-12       Impact factor: 1.443

7.  Recent trends in the incidence, treatment, and prognosis of patients with heart failure and atrial fibrillation (the Worcester Heart Failure Study).

Authors:  David D McManus; Jane S Saczynski; Darleen Lessard; Menhel Kinno; Rahul Pidikiti; Nada Esa; Josephine Harrington; Robert J Goldberg
Journal:  Am J Cardiol       Date:  2013-05-15       Impact factor: 2.778

8.  Ranolazine in the prevention and treatment of atrial fibrillation: A protocol for meta-analysis.

Authors:  Chengdai Yuan; Wei Luo; Xiaocao Ren; Maxiao Ya; Wenlong Yan; Quanbin Hui
Journal:  Medicine (Baltimore)       Date:  2021-04-23       Impact factor: 1.817

Review 9.  Association between Sleep Apnea Hypopnea Syndrome and the Risk of Atrial Fibrillation: A Meta-Analysis of Cohort Study.

Authors:  Enfa Zhao; Shimin Chen; Yajuan Du; Yushun Zhang
Journal:  Biomed Res Int       Date:  2018-01-18       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.